O'Neil Shaun 4

What Happened

• Shaun O'Neil, Chief Operating Officer of PAVmed Inc. (PAVM), received a grant of 110,000 restricted common shares on April 2, 2026. The shares were granted at $0.00 per share (no cash exchanged), reflecting an equity compensation award rather than an open‑market purchase.

Key Details

• Transaction date: 2026-04-02; Filing date: 2026-04-03 (filed the next day).
• Grant: 110,000 restricted shares at $0.00 per share; total reported value $0 (compensation award).
• Vesting: Single vesting date of May 20, 2029; shares subject to forfeiture if requisite service period not completed (per footnote).
• Shares owned after transaction: not specified in the provided filing excerpt.
• No indication of a 10b5-1 plan, sale, exercise, gift, or tax withholding reported in this transaction.

Context

• This is a typical executive equity award (restricted stock) used for compensation and retention. Because the award vests only after a multi‑year service period, it is not an immediate purchase signal for the market and will only convert to tradable shares if vesting and any company conditions are met.